Natural killer T cells and the regulation of asthma

Mucosal Immunology

Volumn 2, Issue 5, 2009, Pages 383-392

  Matangkasombut, P ^a,b   Pichavant, M ^a   DeKruyff, R H ^a   Umetsu, D T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; OVALBUMIN; OZONE; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ASTHMA; CHRONIC LUNG DISEASE; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 69249114907     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.96     Document Type: Review

References (147)

1. Busse, W.W. & Lemanske Jr, R.F. Asthma. N. Engl. J. Med. 344 350-362 (2001).
2. Mannino, D.M., Homa, D.M., Akinbami, L.J., Moorman, J.E., Gwynn, C. & Redd, S.C. Surveillance for asthma - United States, 1980-1999. MMWR Surveill. Summ. 51, 1-13 (2002).
3. Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C. & DeKruyff, R.H. Asthma: An epidemic of dysregulated immunity. Nat. Immunol. 3 715-720 (2002).
4. von Mutius, E. Gene-environment interactions in asthma. J. Allergy Clin. Immunol. 123, 3-11; quiz 2-3 (2009).
5. Vercelli, D. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 8, 169-182 (2008).
6. Anderson, G.P. Endotyping asthma: New insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107-1119 (2008).
7. National Heart Lung and Blood Institute. Title: Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. 2007, Contract no.: Document no item no. 08-4051.
8. Burrows, B., Martinez, F.D., Halonen, M., Barbee, R.A. & Cline, M.G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320, 271-277 (1989).
9. Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281 (1999).
10. Robinson, D.S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326 298-304 (1992).
11. Wills-Karp, M. & Ewart, S.L. The genetics of allergen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 156 (4 Part 2), S89-S96 (1997).
12. Martinez, F.D. et al. Asthma and wheezing in the first six years of life. N. Engl. J. Med. 332, 133-138 (1995).
13. Gavett, S.H., Chen, X., Finkelman, F. & Wills-Karp, M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10, 587-593 (1994).
14. Cohn, L., Elias, J.A. & Chupp, G.L. Asthma: Mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815 (2004).
15. Wenzel, S., Wilbraham, D., Fuller, R., Getz, E.B. & Longphre, M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: Results of two phase 2a studies Lancet 370, 1422-1431 (2007).
16. Leckie, M.J. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144-2148 (2000).
17. Corren, J. Allergic rhinitis and asthma: How important is the link? J. Allergy Clin. Immunol. 99, S781-S786 (1997).
18. Cho, S.H., Stanciu, L.A., Holgate, S.T. & Johnston, S.L. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am. J. Respir. Crit. Care Med. 171, 224-230 (2005).
19. Nakao, F. et al. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J. Allergy Clin. Immunol. 107, 499-504 (2001).
20. Bullens, D.M. et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7, 135 (2006).
21. Oboki, K., Ohno, T., Saito, H. & Nakae, S. Th17 and allergy. Allergol. Int. 57, 121-134 (2008).
22. Pichavant, M. et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 205, 385-393 (2008).
23. Haldar, P. & Pavord, I.D. Noneosinophilic asthma: A distinct clinical and pathologic phenotype. J. Allergy Clin. Immunol. 119, 1043-1052; quiz 1053-1054 (2007).
24. Kay, A.B. Inflammatory cells in bronchial asthma. J. Asthma 26 335-344 (1989).
25. Simpson, J.L., Grissell, T.V., Douwes, J., Scott, R.J., Boyle, M.J. & Gibson, P.G. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62, 211-218 (2007).
26. Chanez, P. et al. Severe asthma in adults: What are the important questions? J. Allergy Clin. Immunol. 119, 1337-1348 (2007).
27. Green, R.H., Brightling, C.E., Woltmann, G., Parker, D., Wardlaw, A.J. & Pavord, I.D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57, 875-879 (2002).
28. Looringh van Beeck, F.A. et al. Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants. Mol. Immunol. 46, 1424-1431 (2009).
29. Van Rhijn, I. et al. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d. J. Immunol. 176, 4888-4893 (2006).
30. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
31. Spada, F.M., Koezuka, Y. & Porcelli, S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529-1534 (1998).
32. Scott-Browne, J.P. et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 8, 1105-1113 (2007).
33. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
34. Taniguchi, M. & Nakayama, T. Recognition and function of Valpha14 NKT cells. Semin. Immunol. 12, 543-550 (2000).
35. Kawano, T. et al. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res. 59, 5102-5105 (1999).
36. Metelitsa, L.S. et al. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167, 3114-3122 (2001).
37. Kinjo, Y. & Kronenberg, M. Valpha14i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes. J. Clin. Immunol. 25, 522-533 (2005).
38. Skold, M. & Behar, S.M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71, 5447-5455 (2003).
39. Terabe, M. & Berzofsky, J.A. The role of NKT cells in tumor immunity. Adv. Cancer Res. 101, 277-348 (2008).
40. Ronchi, F. & Falcone, M. Immune regulation by invariant NKT cells in autoimmunity. Front. Biosci. 13, 4827-4837 (2008).
41. Seino, K.I. et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98, 2577-2581 (2001).
42. Tupin, E. et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199, 417-422 (2004).
43. Umetsu, D.T. & DeKruyff, R.H. A role for natural killer T cells in asthma. Nat. Rev. Immunol. 6, 953-958 (2006).
44. Akbari, O. et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9, 582-588 (2003).
45. Lisbonne, M. et al. Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171, 1637-1641 (2003).
46. Das, J. et al. Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med. 12, 1345-1346; author reply 7 (2006).
47. Korsgren, M. et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553-562 (1999).
48. Bilenki, L., Yang, J., Fan, Y., Wang, S. & Yang, X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol. 34, 345-354 (2004).
49. Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997).
50. Aris, R.M., Christian, D., Hearne, P. Q., Kerr, K., Finkbeiner, W.E. & Balmes, JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 148, 1363-1372 (1993).
51. Gent, J.F. et al. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA 290, 1859-1867 (2003).
52. Rachitskaya, A.V. et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180, 5167-5171 (2008).
53. Michel, M.L. et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
54. Lee, K.A. et al. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol. 251, 50-55 (2008).
55. Coquet, J.M. et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4 - NK1.1 - NKT cell population. Proc. Natl. Acad. Sci. USA 105, 11287-11292 (2008).
56. Goto, M. et al. Murine NKT cells produce Th17 cytokine interleukin-22. Cell Immunol. 254, 81-84 (2009).
57. Gern, J.E. & Busse, W.W. The role of viral infections in the natural history of asthma. J. Allergy Clin. Immunol. 106, 201-212 (2000).
58. Sigurs, N. et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171, 137-141 (2005).
59. Hamelin, M.E., Prince, G.A., Gomez, A. M., Kinkead, R. & Boivin, G. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 193, 1634-1642 (2006).
60. Kim, E.Y. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640 (2008).
61. Brown, D.R. et al. Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184, 1295-1304 (1996).
62. Zhang, Y., Rogers, K.H. & Lewis, D.B. Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184, 1507-1512 (1996).
63. Amano, M. et al. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: Beta 2-microglobulin-dependent and independent forms. J. Immunol. 161, 1710-1717 (1998).
64. Balk, S.P. et al. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265 259-262 (1994).
65. Kim, H.S., Garcia, J., Exley, M., Johnson, K. W., Balk, S.P. & Blumberg, R.S. Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J. Biol. Chem. 274, 9289-9295 (1999).
66. Paduraru, C. et al. An N-linked glycan modulates the interaction between the CD1d heavy chain and beta 2-microglobulin. J. Biol. Chem. 281, 40369-40378 (2006).
67. Maeda, M., Shadeo, A., MacFadyen, A.M. & Takei, F. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172, 6115-6122 (2004).
68. Koh, Y.I. et al. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice. J. Immunol. 181, 4560-4569 (2008).
69. Finotto, S. et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295 336-338 (2002).
70. Szabo, S.J., Sullivan, B.M., Peng, S.L. & Glimcher, L.H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713-758 (2003).
71. Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A. R., Sleckman, B.P. & Glimcher, L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342 (2002).
72. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20, 477-494 (2004).
73. Kim, H.Y. et al. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. J. Immunol. 182, 3252-3261 (2009).
74. Akbari, O. et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
75. Sen, Y. et al. V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J. Immunol. 175, 4914-4926 (2005).
76. Pham-Thi, N., de Blic, J., Le Bourgeois, M., Dy, M., Scheinmann, P. & Leite-de-Moraes, M.C. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J. Allergy Clin. Immunol. 117, 217-218 (2006).
77. Hamzaoui, A. et al. NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm. 2006, 71214 (2006).
78. Yamamoto, H., Okamoto, Y., Horiguchi, S., Kunii, N., Yonekura, S. & Nakayama, T. Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy 62, 1451-1455 (2007).
79. Russano, A.M., Agea, E., Casciari, C., de Benedictis, F.M. & Spinozzi, F. Complementary roles for lipid and protein allergens in triggering innate and adaptive immune systems. Allergy 63, 1428-1437 (2008).
80. Fujiki, R., Yokoyama, T., Watson, R., Gauvreau, G. & O'Byrne, P. NKT cells in sputum and peripheral blood from subjects with allergen-induced late asthmatic responses. J. Resp. Crit. Care Med. 2007; ATS abstracts: A680 (2007).
81. Matangkasombut, P. et al. Natural killer T cells in the lungs of patients with asthma. J. Allergy Clin. Immunol. (2009).
82. Mutalithas, K. et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J. Allergy Clin. Immunol. 119, 1274-1276 (2007).
83. Vijayanand, P. et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 356 1410-1422 (2007).
84. Thomas, S.Y., Lilly, C.M. & Luster, A.D. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 2613-2616; author reply: 2613-2616 (2006).
85. Bratke, K., Julius, P. & Virchow, J.C. Invariant natural killer T cells in obstructive pulmonary diseases. N. Engl. J. Med. 357, 194; author reply: 194-145 (2007).
86. Nguyen, K.D., Vanichsarn, C. & Nadeau, K.C. Increased cytotoxicity of CD4+ invariant NKT cells against CD4+CD25hiCD127lo/-regulatory T cells in allergic asthma. Eur. J. Immunol. 38, 2034-2045 (2008).
87. Matangkasombut, P. et al. Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates. J. Allergy Clin. Immunol. 121, 1287-1289 (2008).
88. Coffman, R.L. & Hessel, E.M. Nonhuman primate models of asthma. J. Exp. Med. 201, 1875-1879 (2005).
89. Meyer, E.H. et al. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J. Immunol. 179 4661-4671 (2007).
90. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
91. Giabbai, B. et al. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: A molecular basis for NKT cell activation. J. Immunol. 175, 977-984 (2005).
92. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
93. Rauch, J. et al. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278, 47508-47515 (2003).
94. Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M. & Chapman, P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003).
95. Zajonc, D.M. et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6, 810-818 (2005).
96. Meyer, E.H. et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103, 2782-2787 (2006).
97. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
98. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
99. Tsuji, M. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell. Mol. Life Sci. 63, 1889-1898 (2006).
100. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986 (2006).
101. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101, 10685-10690 (2004).
102. Gilleron, M., Ronet, C., Mempel, M., Monsarrat, B., Gachelin, G. & Puzo, G. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. J. Biol. Chem. 276, 34896-34904 (2001).
103. Amprey, J.L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904 (2004).
104. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003).
105. Paget, C. et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597-609 (2007).
106. Kim, S., Lalani, S., Parekh, V.V., Vincent, T.L., Wu, L. & Van Kaer, L. Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J. Clin. Invest. 118 2301-2315 (2008).
107. Tyznik, A.J., Tupin, E., Nagarajan, N.A., Her, M.J., Benedict, C.A. & Kronenberg, M. Cutting edge: The mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181, 4452-4456 (2008).
108. Nagarajan, N.A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706-2713 (2007).
109. Agea, E. et al. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202, 295-308 (2005).
110. Letuve, S. et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J. Allergy Clin. Immunol. 117, 590-596 (2006).
111. Owyang, A.M. et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203, 843-849 (2006).
112. Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001).
113. Angkasekwinai, P. et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517 (2007).
114. Tamachi, T. et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J. Allergy Clin. Immunol. 118, 606-614 (2006).
115. Ballantyne, S.J. et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol. 120, 1324-1331 (2007).
116. Terashima, A. et al. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205, 2727-2733 (2008).
117. Stock, P., Lombardi, V., Kohlrautz, V. & Akbari, O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J. Immunol. 182, 5116-5122 (2009).
118. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
119. Baekkevold, E.S. et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163, 69-79 (2003).
120. Kondo, Y. et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20, 791-800 (2008).
121. Bourgeois, E. et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39, 1046-1055 (2009).
122. Smithgall, M.D., Comeau, M.R., Yoon, B.R., Kaufman, D., Armitage, R. & Smith, D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20, 1019-1030 (2008).
123. Liu, Y.J. TSLP in epithelial cell and dendritic cell cross talk. Adv. Immunol. 101, 1-25 (2009).
124. Liu, Y.J. et al. TSLP: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25, 193-219 (2007).
125. Watanabe, N., Hanabuchi, S., Marloie-Provost, M. A., Antonenko, S., Liu, Y.J. & Soumelis, V. Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential. Blood 105, 4749-4751 (2005).
126. Nagata, Y., Kamijuku, H., Taniguchi, M., Ziegler, S. & Seino, K. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int. Arch. Allergy Immunol. 144, 305-314 (2007).
127. Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89 (2008).
128. Fang, L., Adkins, B., Deyev, V. & Podack, E.R. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205, 1037-1048 (2008).
129. Akbari, O. et al. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J. Immunol. 180, 5448-5456 (2008).
130. Yoshimoto, T. et al. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197, 997-1005 (2003).
131. Yamagata, S., Tomita, K., Sato, R., Niwa, A., Higashino, H. & Tohda, Y. Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model. Clin. Exp. Immunol. 154, 295-304 (2008).
132. Hachem, P. et al. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role of IFN-gamma. Eur. J. Immunol. 35, 2793-2802 (2005).
133. Matsuda, H. et al. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33, 22-31 (2005).
134. Morishima, Y. et al. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur. J. Immunol. 35, 2803-2814 (2005).
135. Dombrowicz, D. Exploiting the innate immune system to control allergic asthma. Eur. J. Immunol. 35, 2786-2788 (2005).
136. Kawano, T. et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 95, 5690-5693 (1998).
137. Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T. & Taniguchi, M. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J. Immunol. 163, 2387-2391 (1999).
138. Nagaraj, S., Ziske, C., Strehl, J., Messmer, D., Sauerbruch, T. & Schmidt-Wolf, I.G. Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo. Int. Immunol. 18, 1279-1283 (2006).
139. Hayakawa, Y., Rovero, S., Forni, G. & Smyth, M.J. Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis. Proc. Natl. Acad. Sci. USA 100, 9464-9469 (2003).
140. Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R.M. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3, 867-874 (2002).
141. Ishikawa, A. et al. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 11, 1910-1917 (2005).
142. Okai, M. et al. Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox. Sang. 83, 250-253 (2002).
143. Uchida, T. et al. Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol. Immunother. 57, 337-345 (2008).
144. Fujii, S. et al. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA (2006)## 103, 11252-11257.
145. Schmieg, J., Yang, G., Franck, R.W. & Tsuji, M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide. J. Exp. Med. 198, 1631-1641 (2003).
146. Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531-534 (2001).
147. Oki, S., Chiba, A., Yamamura, T. & Miyake, S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113, 1631-1640 (2004).